Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeloytic leukemia-derived NB4 cells

被引:34
作者
Cao, Ting-Ming
Hua, Fang-Yuan
Xu, Cai-Min [1 ]
Han, Bing-She
Dong, Hua
Zuo, Lu
Wang, Xuan
Yang, Yang
Pan, Hua-Zhen
Zhang, Zhi-Nan
机构
[1] Peking Union Med Coll, Inst Basic Med, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100005, Peoples R China
[3] Peking Union Med Coll, Peking Union Hosp, Dept Hematol, Beijing 100730, Peoples R China
关键词
sodium selenite; acute promyelocytic leukemia; apoptosis; cDNA microarray;
D O I
10.1007/s00277-005-0046-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Selenium at a low concentration has a chemopreventive role against cancer, while at a high concentration, it exerts a direct antitumor effect. However, the mechanisms remain elusive. In this article, we discovered that Na2SeO3 at 20 mu mol/l concentration could significantly inhibit the proliferation of NB4 cells, affect the cell cycle distribution of cell population, and induce cellular changes characteristic of apoptotic cells, while this same compound at 2 mu mol/l concentration had no such effects. The mechanisms underlying these overt differences caused by treatment of different concentrations of selenium were further investigated. cDNA microarray analysis showed that after treatment by 20 mu mol/l Na2SeO3, 34 genes were changed in expression, while treatment by 2 mu mol/l Na2SeO3 resulted in the changes of 29 genes. Nine genes were regulated in both groups, among which three showed opposite changes caused by 2 and 20 mu mol/l Na2SeO3. The majority of regulated genes did not coincide between the two experiment groups. In conclusion, 2 and 20 mu mol/l Na2SeO3 could have different effects on NB4 cells, and some genes might be involved in the underlying mechanisms. Our findings could provide basis for further uncovering the molecular mechanisms of the chemopreventive and antitumor effects of selenium and, in turn, for probing the rationality of treating leukemia with selenium.
引用
收藏
页码:434 / 442
页数:9
相关论文
共 27 条
[1]   Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression [J].
Barrett, JC ;
Kawasaki, ES .
DRUG DISCOVERY TODAY, 2003, 8 (03) :134-141
[2]   Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells [J].
Bellosillo, B ;
Dalmau, M ;
Colomer, D ;
Gil, J .
BLOOD, 1997, 89 (09) :3378-3384
[3]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[4]   Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide [J].
Camacho, LH ;
Soignet, SL ;
Chanel, S ;
Ho, R ;
Heller, G ;
Scheinberg, DA ;
Ellison, R ;
Warrell, RP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2620-2625
[5]  
Chen GQ, 1997, BLOOD, V89, P3345
[6]   The link between selenium and chemoprevention: A case for selenoproteins [J].
Diwadkar-Navsariwala, V ;
Diamond, AM .
JOURNAL OF NUTRITION, 2004, 134 (11) :2899-2902
[7]  
Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630
[8]   Mechanisms of mammary cancer chemoprevention by organoselenium compounds [J].
El-Bayoumy, K ;
Sinha, R .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 551 (1-2) :181-197
[9]   The protective role of selenium on genetic damage and on cancer [J].
El-Bayoumy, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 475 (1-2) :123-139
[10]   All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia [J].
Fenaux, P ;
Chomienne, C ;
Degos, L .
SEMINARS IN HEMATOLOGY, 2001, 38 (01) :13-25